News for Healthier Living

CHLA-Led Behavioral Health Team Receives $6.4 Million Research Grant for Clinical Trial on Combined Treatments for Pediatric Anxiety

The new clinical trial will explore how the antidepressant fluoxetine, a selective serotonin reuptake inhibitor (SSRI) that works by increasing activity of serotonin, the mood-regulating chemical in the brain, can be used on its own or in combination with cognitive behavioral therapy to effectively treat pediatric anxiety. While Dr. Peterson's previous research has shown how these treatments can address anxiety symptoms over a short period, the new study will shed light on the long-term impacts of the treatments, which will be helpful to families deciding between various treatment options.

June 2, 2025


June 3 2025

June 2 2025

June 1 2025

May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025

May 23 2025

May 22 2025

May 21 2025